Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Nakaraang pagsara
¥16.79
Sakop ng araw
¥16.65 - ¥16.90
Sakop ng taon
¥13.10 - ¥21.39
Market cap
18.38B CNY
Average na Volume
19.63M
P/E ratio
336.56
Dividend yield
0.54%
Primary exchange
SHE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 746.86M | -0.47% |
Gastos sa pagpapatakbo | 545.63M | 14.03% |
Net na kita | 15.10M | -86.43% |
Net profit margin | 2.02 | -86.38% |
Kita sa bawat share | — | — |
EBITDA | 41.21M | -73.10% |
Aktuwal na % ng binabayarang buwis | 156.17% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.44B | 221.80% |
Kabuuang asset | 14.13B | -2.19% |
Kabuuang sagutin | 4.53B | -7.75% |
Kabuuang equity | 9.60B | — |
Natitirang share | 1.12B | — |
Presyo para makapag-book | 1.95 | — |
Return on assets | -1.00% | — |
Return on capital | -1.23% | — |
Cash Flow
Net change in cash
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 15.10M | -86.43% |
Cash mula sa mga operasyon | 121.90M | -8.83% |
Cash mula sa pag-invest | 62.96M | -23.54% |
Cash mula sa financing | -187.09M | 75.28% |
Net change in cash | -2.37M | 99.56% |
Malayang cash flow | 2.56B | 636.57% |
Tungkol
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Itinatag
Set 8, 1992
Website
Mga Empleyado
1,913
